South Martin's Form 4 filing
Marsh & McLennan Companies, Inc.MRSH · filed Mar 5, 2025
- Accession no.
- 0001127602-25-008283
- Filed
- Mar 5, 2025
- Trade date
- Mar 4, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $6.34M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| South MartinCIK 0001901227 | Officer (President & CEO, Marsh) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | Common Stock | SSaleDisposed | −2,000 | $239.96F1 | −$479,920 | 17,062.52 | Direct | |
| Mar 4, 2025 | Common Stock | MOption exerciseAcquired | +12,620 | $90.79 | +$1,145,769.8 | 29,682.52 | Direct | |
| Mar 4, 2025 | Common Stock | MOption exerciseAcquired | +11,856 | $118.87 | +$1,409,322.72 | 41,538.52 | Direct | |
| Mar 4, 2025 | Common Stock | SSaleDisposed | −11,856 | $239.47F2 | −$2,839,156.32 | 29,682.52 | Direct | |
| Mar 4, 2025 | Common Stock | SSaleDisposed | −6,028 | $239.20F3 | −$1,441,897.6 | 23,654.52 | Direct | |
| Mar 4, 2025 | Common Stock | SSaleDisposed | −6,592 | $240.04F4 | −$1,582,343.68 | 17,062.52 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | Common Stock | MOption exerciseDisposed | −12,620 | $0.00 | $0 | 0 | Direct | |
| Mar 4, 2025 | Common Stock | MOption exerciseDisposed | −11,856 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $239.840 to $239.970. The price reported represents the weighted average sale price of these trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F2
This transaction was executed in multiple trades at prices ranging from $239.040 to $239.830. The price reported represents the weighted average sale price of these trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $238.610 to $239.600. The price reported represents the weighted average sale price of these trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $239.720 to $240.460. The price reported represents the weighted average sale price of these trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.